Comparison of 24-h Urinary Aldosterone Level and Random Urinary Aldosterone-to-Creatinine Ratio in the Diagnosis of Primary Aldosteronism

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Wu, Che Hsiung ^a   Yang, Ya Wen ^b   Hu, Ya Hui ^a   Tsai, Yao Chou ^a   Kuo, Ko Lin ^a   Lin, Yen Hung ^b   Hung, Szu Chun ^a   Wu, Vin Cent ^b   Wu, Kwan Dun ^b   Ho, Yi Luwn ^c   Chang, Hung Wei ^c   Lin, Lian Yu ^c   Hu, Fu Chang ^c   Liu, Kao Lang ^c   Wang, Shuo Meng ^c   Huang, Kuo How ^c   Chen, Yung Ming ^c   Kuo, Chin Chi ^c   Chang, Chin Chen ^c   Chueh, Shih Chieh ^c   Lu, Ching Chu ^c   Liao, Shih Cheng ^c   Yen, Ruoh Fang ^c   more..

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c Buddhist Tzu Chi General Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CREATININE;

ADRENAL CORTEX ADENOMA; ADULT; ALDOSTERONE CREATININE RATIO; ALDOSTERONE URINE LEVEL; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; ESSENTIAL HYPERTENSION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOKALEMIA; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIMARY HYPERALDOSTERONISM; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; RENAL SYSTEM PARAMETERS; SALT LOADING; SENSITIVITY AND SPECIFICITY; URINALYSIS;

ADENOMA; ADRENAL GLAND NEOPLASMS; ADULT; ALDOSTERONE; CREATININE; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ROC CURVE;

EID: 84879515409     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067417     Document Type: Article

References (33)

1. Wu KD, Liao TS, Chen YM, Lai MK, Chen SJ, et al. (2001) Preoperative diagnosis and localization of aldosterone-producing adenoma by adrenal venous sampling after administration of metoclopramide. J Formos Med Assoc 100: 598-603.
2. Young WF Jr, (2003) Minireview: primary aldosteronism-changing concepts in diagnosis and treatment. Endocrinology 144: 2208-2213.
3. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, et al. (2006) A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48: 2293-2300.
4. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, et al. (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45: 1243-1248.
5. Stowasser M, Ahmed AH, Pimenta E, Taylor PJ, Gordon RD, (2012) Factors affecting the aldosterone/renin ratio. Horm Metab Res 44: 170-176.
6. Abdelhamid S, Blomer R, Hommel G, Haack D, Lewicka S, et al. (2003) Urinary tetrahydroaldosterone as a screening method for primary aldosteronism: a comparative study. Am J Hypertens 16: 522-530.
7. Charloux A, Gronfier C, Lonsdorfer-Wolf E, Piquard F, Brandenberger G, (1999) Aldosterone release during the sleep-wake cycle in humans. Am J Physiol 276: E43-49.
8. Schirpenbach C, Seiler L, Maser-Gluth C, Rudiger F, Nickel C, et al. (2006) Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites. Eur J Endocrinol 154: 865-873.
9. Mourad JJ, Girerd X, Milliez P, Lopez-Sublet M, Lejeune S, et al. (2008) Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas. Am J Hypertens 21: 742-747.
10. Brown CA, Bouldin MJ, Blackston JW, Duddleston DN, Shepherd JM, et al. (2002) Hyperaldosteronism: the internist's hypertensive disease. Am J Med Sci 324: 227-231.
11. Ginsberg JM, Chang BS, Matarese RA, Garella S, (1983) Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 309: 1543-1546.
12. Kuo CC, Wu VC, Huang KH, Wang SM, Chang CC, et al. (2011) Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group). J Renin Angiotensin Aldosterone Syst 12: 348-357.
13. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, et al. (2008) Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93: 3266-3281.
14. Yen RF, Wu VC, Liu KL, Cheng MF, Wu YW, et al. (2009) 131I-6beta-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results. J Nucl Med 50: 1631-1637.
15. Wu VC, Chao CT, Kuo CC, Lin YH, Chueh SC, et al. (2012) Diagnosis and Management of Primary Aldosteronism. Acta Nephrologica 26: 111-120.
16. Nomura K, Toraya S, Horiba N, Ujihara M, Aiba M, et al. (1992) Plasma aldosterone response to upright posture and angiotensin II infusion in aldosterone-producing adenoma. J Clin Endocrinol Metab 75: 323-327.
17. Omura M, Sasano H, Fujiwara T, Yamaguchi K, Nishikawa T, (2002) Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling. Metabolism 51: 350-355.
18. Novitsky YW, Kercher KW, Rosen MJ, Cobb WS, Jyothinagaram S, et al. (2005) Clinical outcomes of laparoscopic adrenalectomy for lateralizing nodular hyperplasia. Surgery 138: 1009-1016; discussion 1016-1007.
19. Rossi GP, Belfiore A, Bernini G, Desideri G, Fabris B, et al. (2007) Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 50: 424-431.
20. Wu VC, Chang HW, Liu KL, Lin YH, Chueh SC, et al. (2009) Primary aldosteronism: diagnostic accuracy of the losartan and captopril tests. Am J Hypertens 22: 821-827.
21. Wu VC, Yang SY, Lin JW, Cheng BW, Kuo CC, et al. (2011) Kidney impairment in primary aldosteronism. Clin Chim Acta 412: 1319-1325.
22. Chang HW, Chu TS, Huang HY, Chueh SC, Wu VC, et al. (2007) Down-regulation of D2 dopamine receptor and increased protein kinase Cmu phosphorylation in aldosterone-producing adenoma play roles in aldosterone overproduction. J Clin Endocrinol Metab 92: 1863-1870.
23. Bland JM, Altman DG, (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307-310.
24. Passing H, Bablok W, (1983) A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem 21: 709-720.
25. Persson F, Lewis JB, Lewis EJ, Rossing P, Hollenberg NK, et al. (2012) Impact of aliskiren treatment on urinary aldosterone levels in patients with type 2 diabetes and nephropathy: an AVOID substudy. J Renin Angiotensin Aldosterone Syst 13: 118-121.
26. Steichen O, Blanchard A, Plouin PF, (2011) Assessment of serum sodium to urinary sodium divided by (serum potassium)(2) to urinary potassium as a screening tool for primary aldosteronism. Eur J Clin Invest 41: 189-194.
27. Montori VM, Schwartz GL, Chapman AB, Boerwinkle E, Turner ST, (2001) Validity of the aldosterone-renin ratio used to screen for primary aldosteronism. Mayo Clin Proc 76: 877-882.
28. Mulatero P, Dluhy RG, Giacchetti G, Boscaro M, Veglio F, et al. (2005) Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends Endocrinol Metab 16: 114-119.
29. Bravo EL, (1994) Primary aldosteronism. Issues in diagnosis and management. Endocrinol Metab Clin North Am 23: 271-283.
30. Holland OB, (1995) Primary aldosteronism. Semin Nephrol 15: 116-125.
31. Gomez-Sanchez CE, Holland OB, (1981) Urinary tetrahydroaldosterone and aldosterone-18-glucuronide excretion in white and black normal subjects and hypertensive patients. J Clin Endocrinol Metab 52: 214-219.
32. Martinerie L, Pussard E, Foix-L'Helias L, Petit F, Cosson C, et al. (2009) Physiological partial aldosterone resistance in human newborns. Pediatr Res 66: 323-328.
33. Djajadiningrat-Laanen SC, Galac S, Cammelbeeck SE, van Laar KJ, Boer P, et al. (2008) Urinary aldosterone to creatinine ratio in cats before and after suppression with salt or fludrocortisone acetate. J Vet Intern Med 22: 1283-1288.